Silva's most recent trade in Fresh Del Monte Produce Inc was a trade of 1,315 Ordinary Shares done at an average price of $37.5 . Disclosure was reported to the exchange on Aug. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Sale of securities on an exchange or to another person at price $ 37.54 per share. | 04 Aug 2025 | 1,315 | 7,377 (0%) | 0% | 37.5 | 49,365 | Ordinary Shares |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2025 | 51,500 | 51,500 | - | - | Stock Option (right to Buy) | |
| Jupiter Neurosciences Inc | Alison D. Silva | Pres + Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2025 | 255,320 | 255,320 | - | - | Stock Option (right to buy) | |
| ClearSign Technologies Corp | Gil Todd Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 32,638 | 93,639 | - | - | Restricted Stock Units | |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 01 Jul 2025 | 250 | 112,777 | - | 1.0 | 259 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 01 Jul 2025 | 250 | 112,527 | - | 1.0 | 257 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 01 Jul 2025 | 250 | 112,277 | - | 1.0 | 257 | Common Stock |
| Cencora | Silvana Battaglia | Executive Vice President | Grant, award, or other acquisition of securities at price $ 257.69 per share. | 30 Jun 2025 | 52 | 11,349 (0%) | 0% | 257.7 | 13,400 | Common Stock |
| Cencora | Silvana Battaglia | Executive Vice President | Sale of securities on an exchange or to another person at price $ 297.40 per share. | 18 Jun 2025 | 4,077 | 11,296 (0%) | 0% | 297.4 | 1,212,520 | Common Stock |
| Rapport Therapeutics Inc. | Paul M. Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 10,925 | 10,925 | - | - | Stock Option (Right to Buy) | |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 110,227 | 110,227 | - | 0 | Common Stock | |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 02 Jun 2025 | 250 | 111 | - | 1.0 | 255 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 02 Jun 2025 | 250 | 111,927 | - | 1.0 | 259 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 02 Jun 2025 | 250 | 111,677 | - | 1.0 | 258 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 02 Jun 2025 | 250 | 110,477 | - | 1 | 250 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 02 Jun 2025 | 250 | 110,827 | - | 1.0 | 261 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.05 per share. | 02 Jun 2025 | 250 | 111,077 | - | 1.1 | 263 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.05 per share. | 02 Jun 2025 | 100 | 112,027 | - | 1.1 | 105 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 02 Jun 2025 | 100 | 110,577 | - | 1.0 | 104 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 02 Jun 2025 | 100 | 111,177 | - | 1.0 | 102 | Common Stock |
| Agilon Health Inc | Silvana Battaglia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 78,724 | 144,868 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Paul M. Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 25,000 | 25,000 | - | - | Director Stock Option (right to buy) | |
| Community West Bancshares. | Dorothea D. Silva | Director | Purchase of securities on an exchange or from another person at price $ 18.85 per share. | 09 May 2025 | 84 | 12,127 (0%) | 0% | 18.8 | 1,583 | CWBC - Common Stock |
| Anywhere Real Estate Inc | Enrique Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 43,127 | 186,778 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Community West Bancshares. | Dorothea D. Silva | Director | Grant, award, or other acquisition of securities at price $ 17.60 per share. | 07 May 2025 | 1,819 | 12,043 (0%) | 0% | 17.6 | 32,014 | CWBC - Common Stock |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 13,956 | 82,230 (0%) | 0% | 0 | Common Stock | |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 52.22 per share. | 15 Apr 2025 | 6,740 | 75,490 (0%) | 0% | 52.2 | 351,963 | Common Stock |
| ClearSign Technologies Corp | Gil Todd Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 19,369 | 61,001 | - | - | Restricted Stock Units | |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Community West Bancshares. | Dorothea D. Silva | Director | Purchase of securities on an exchange or from another person at price $ 18.50 per share. | 19 Mar 2025 | 56 | 10,224 (0%) | 0% | 18.5 | 1,036 | CWBC - Common Stock |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 13,966 | 69,215 (0%) | 0% | 0 | Common Stock | |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 53.70 per share. | 04 Mar 2025 | 941 | 68,274 (0%) | 0% | 53.7 | 50,532 | Common Stock |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 6,328 | 6,328 | - | - | Restricted Stock Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 6,328 | 6,328 | - | - | Performance Stock Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Sale of securities on an exchange or to another person at price $ 30.42 per share. | 03 Mar 2025 | 2,124 | 8,692 (0%) | 0% | 30.4 | 64,612 | Ordinary Shares |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 5,188 | 10,378 | - | - | Performance Stock Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 5,188 | 7,997 (0%) | 0% | 0 | Ordinary Shares | |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 57.35 per share. | 01 Mar 2025 | 1,520 | 55,249 (0%) | 0% | 57.4 | 87,172 | Common Stock |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 1,042 | 9,794 (0%) | 0% | 0 | Ordinary Shares | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 1,042 | 1,045 | - | - | Restricted Stock Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 841 | 0 | - | - | Performance Stock Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 841 | 10,635 (0%) | 0% | 0 | Ordinary Shares | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 562 | 0 | - | - | Restricted Stock Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 562 | 8,752 (0%) | 0% | 0 | Ordinary Shares | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 193 | 638 | - | - | Dividend Equivalent Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 193 | 8,190 (0%) | 0% | 0 | Ordinary Shares | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 181 | 456 | - | - | Dividend Equivalent Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 181 | 10,816 (0%) | 0% | 0 | Ordinary Shares | |
| MoonLake Immunotherapeutic... | Jorge Santos da Silva | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 95,763 | 3,078,577 | - | 0 | Class A ordinary shares, par value $0.0001 per share | |
| Cencora | Silvana Battaglia | Executive Vice President | Sale of securities on an exchange or to another person at price $ 242.24 per share. | 21 Feb 2025 | 5,000 | 15,373 (0%) | 0% | 242.2 | 1,211,200 | Common Stock |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 17,630 | 17,630 | - | - | Stock Option (right to Buy) | |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 768,979 | 768,979 | - | - | Stock Option | |
| Illinois Tool Works | Guilherme de Figueiredo Silva | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 8,336 | 8,336 | - | - | Employee Stock Option | |
| Illinois Tool Works | Guilherme de Figueiredo Silva | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 604 | 0 | - | - | Performance Share Units (granted 2/11/22) | |
| Illinois Tool Works | Guilherme de Figueiredo Silva | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 604 | 2,348 (0%) | 0% | - | Common Stock | |
| Illinois Tool Works | Guilherme de Figueiredo Silva | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 260.09 per share. | 13 Feb 2025 | 196 | 2,152 (0%) | 0% | 260.1 | 50,978 | Common Stock |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 52.31 per share. | 11 Feb 2025 | 1,202 | 56,769 (0%) | 0% | 52.3 | 62,877 | Common Stock |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 52.89 per share. | 09 Feb 2025 | 1,255 | 57,971 (0%) | 0% | 52.9 | 66,377 | Common Stock |
| Inari Medical Inc | Karen Silva | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 5,504 | 14,719 | - | 0 | Common Stock | |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 2,748 | 2,748 | - | - | Stock Option (right to Buy) | |
| ClearSign Technologies Corp | Gil Todd Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 10,791 | 41,632 | - | - | Restricted Stock Units | |
| Cartesian Therapeutics Inc | Nishan de Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Nishan de Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 2,600 | 8,766 (0%) | 0% | 0 | Common Stock | |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Cencora | Silvana Battaglia | Executive Vice President | Grant, award, or other acquisition of securities at price $ 194.50 per share. | 31 Dec 2024 | 44 | 20,373 (0%) | 0% | 194.5 | 8,558 | Common Stock |
| Cencora | Battaglia Silvana | Executive Vice President | Sale of securities on an exchange or to another person at price $ 228.72 per share. | 20 Dec 2024 | 1,678 | 20,329 (0%) | 0% | 228.7 | 383,792 | Common Stock |
| Agilon Health Inc | Silvana Battaglia | Director | Purchase of securities on an exchange or from another person at price $ 2.01 per share. | 11 Dec 2024 | 25,062 | 66,144 | - | 2.0 | 50,269 | Common Stock |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 147 | 831 | - | - | Dividend Equivalent Units | |
| ACI Worldwide Inc | da Silva Alessandro | Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 56.43 per share. | 04 Dec 2024 | 980 | 59,226 (0%) | 0% | 56.4 | 55,301 | Common Stock |
| Inari Medical Inc | Silva Karen | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2024 | 9,215 | 9,215 | - | 0 | Common Stock | |
| Cencora | Silvana Battaglia | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 14,276 | 28,225 (0%) | 0% | 0 | Common Stock | |
| Cencora | Silvana Battaglia | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 225.08 per share. | 20 Nov 2024 | 6,218 | 22,007 (0%) | 0% | 225.1 | 1,399,547 | Common Stock |
| Cencora | Silvana Battaglia | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 2,797 | 2,797 | - | - | Restricted Stock Units | |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 55.82 per share. | 09 Nov 2024 | 1,250 | 60,206 (0%) | 0% | 55.8 | 69,775 | Common Stock |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 58.01 per share. | 09 Nov 2024 | 1,210 | 61,456 (0%) | 0% | 58.0 | 70,192 | Common Stock |
| Cencora | Silvana Battaglia | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 2,971 | 0 | - | - | Restricted Stock Units | |
| Cencora | Silvana Battaglia | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 2,971 | 13,919 (0%) | 0% | - | Common Stock | |
| Cencora | Silvana Battaglia | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.41 per share. | 08 Nov 2024 | 1,294 | 12,625 (0%) | 0% | 248.4 | 321,443 | Common Stock |
| Cencora | Silvana Battaglia | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 1,264 | 13,889 (0%) | 0% | - | Common Stock | |
| Cencora | Silvana Battaglia | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 1,264 | 1,265 | - | - | Restricted Stock Units | |
| Cencora | Silvana Battaglia | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 1,084 | 2,169 | - | - | Restricted Stock Units | |
| Cencora | Silvana Battaglia | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 1,084 | 14,422 (0%) | 0% | - | Common Stock | |
| Cencora | Silvana Battaglia | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.41 per share. | 08 Nov 2024 | 551 | 13,338 (0%) | 0% | 248.4 | 136,874 | Common Stock |
| Cencora | Silvana Battaglia | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.41 per share. | 08 Nov 2024 | 473 | 13,949 (0%) | 0% | 248.4 | 117,498 | Common Stock |
| CCC Intelligent Solutions ... | Michael John Silva | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Oct 2024 | 29,076 | 0 | - | - | Restricted Stock Unit | |
| CCC Intelligent Solutions ... | Michael John Silva | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.33 per share. | 21 Oct 2024 | 29,076 | 59,248 | - | 11.3 | 329,431 | Common Stock |
| CCC Intelligent Solutions ... | Michael John Silva | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.33 per share. | 21 Oct 2024 | 10,482 | 48,766 | - | 11.3 | 118,761 | Common Stock |
| ClearSign Technologies Corp | Gil Todd Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 18,477 | 30,841 | - | - | Restricted Stock Units | |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Community West Bancshares. | Dorothea D. Silva | Director | Sale of securities on an exchange or to another person at price $ 20.07 per share. | 13 Sep 2024 | 1,400 | 10,168 (0%) | 0% | 20.1 | 28,098 | CWBC - Common Stock |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 167 | 684 | - | - | Dividend Equivalent Units | |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 48.58 per share. | 04 Sep 2024 | 975 | 62,666 (0%) | 0% | 48.6 | 47,366 | Common Stock |
| CCC Intelligent Solutions ... | Michael John Silva | See Remarks | Sale of securities on an exchange or to another person at price $ 10.75 per share. | 21 Aug 2024 | 29,022 | 30,172 | - | 10.8 | 312,100 | Common Stock |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 46.59 per share. | 09 Aug 2024 | 1,241 | 63,641 (0%) | 0% | 46.6 | 57,818 | Common Stock |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 46.59 per share. | 09 Aug 2024 | 1,201 | 64,882 (0%) | 0% | 46.6 | 55,955 | Common Stock |
| Cencora | Silvana Battaglia | Executive Vice President | Sale of securities on an exchange or to another person at price $ 242.69 per share. | 06 Aug 2024 | 1,473 | 10,948 (0%) | 0% | 242.7 | 357,482 | Common Stock |
| ClearSign Technologies Corp | Gil Todd Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 12,364 | 12,364 | - | - | Restricted Stock Units | |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Cencora | Silvana Battaglia | Executive Vice President | Grant, award, or other acquisition of securities at price $ 192.30 per share. | 28 Jun 2024 | 66 | 12,421 (0%) | 0% | 192.3 | 12,692 | Common Stock |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 63,324 | 63,324 | - | - | Stock Option (right to Buy) |